help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jamieson, A.
Right arrow Articles by Connell, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jamieson, A.
Right arrow Articles by Connell, J. M.

Journal of Clinical Endocrinology & Metabolism, Vol 81, 2298-2302, Copyright © 1996 by Endocrine Society

ARTICLES

Altered 11 beta-hydroxylase activity in glucocorticoid-suppressible hyperaldosteronism

A Jamieson, MC Ingram, GC Inglis, E Davies, R Fraser and JM Connell
Department of Medicine and Therapeutics, Western Infirmary, Glasgow, Scotland.

Corticosteroid 11 beta-hydroxylation is catalyzed by 11 beta- hydroxylase and aldosterone synthase. Using plasma steroid ratios, the level of this process in patients with glucocorticoid-suppressible hyperaldosteronism (GSH) was compared with that in unaffected control subjects and patients with Conn's syndrome. Based on both 11- deoxycortisol/cortisol (S:F) and 11-deoxycorticosterone/corticosterone (DOC:B) ratios, patients with GSH showed impaired resting 11 beta- hydroxylase activity. In GSH, but not in the other groups, the S:F ratio was significantly correlated with the basal plasma aldosterone concentration. ACTH infusion increased the S:F ratio in all of these patient groups, suggesting a common partial deficiency. The results also indicate that 11 beta-hydroxylation may be rate limiting in normal subjects. In control subjects and patients with Conn's syndrome, the DOC:B ratio was not affected by ACTH. However, in GSH patients, this ratio fell markedly, indicating an increased efficiency of 11 beta- hydroxylation of DOC (but not S). This may be due to the activation by ACTH of the zona fasciculata chimeric aldosterone synthase characteristic of this disease. Plasma aldosterone, corticosterone, and DOC concentrations appeared to be more sensitive to ACTH in GSH than in the other groups. The defect in 11 beta-hydroxylation in GSH accounts for the increased levels of DOC reported in this condition and may contribute to the phenotype variability.


This article has been cited by other articles:


Home page
 HypertensionHome page
J. M.C. Connell, R. Fraser, S. MacKenzie, and E. Davies
Is Altered Adrenal Steroid Biosynthesis a Key Intermediate Phenotype in Hypertension?
Hypertension, May 1, 2003; 41(5): 993 - 999.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Fisher, R. Fraser, J. MC Connell, and E. Davies
Amino Acid Residue 147 of Human Aldosterone Synthase and 11{beta}-Hydroxylase Plays a Key Role in 11{beta}-Hydroxylation
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1261 - 1266.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Stowasser, M. G. Gartside, W. L. Taylor, T. J. Tunny, and R. D. Gordon
In Familial Hyperaldosteronism Type I, Hybrid Gene-Induced Aldosterone Production Dominates That Induced by Wild-Type Genes
J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3670 - 3676.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society